MedPage Today reports that another study links pioglitazone with bladder cancer in the U.K. I’m not sure how the U.S. Food and Drug Administration will react to this.
We have 11 classes of drugs for treatment of diabetes. Thiazolidinediones, aka glitazones or TZDs, are one class. Pioglitazone and rosiglitazone are the only two drugs in the class, at least in the U.S. Rosiglitazone is already highly restricted due to concern about heart toxicity.
This latest news confirms my inclination to treat type 2 diabetes with weight management, exercise, and a low-carbohydrate diet, when able.
2 responses to “Pioglitazone and Bladder Cancer”
Pingback: Trouble Seeing? Might Be Your Diabetes Drug | Diabetic Mediterranean Diet
Pingback: Pioglitazona aumenta o risco de câncer de bexiga em adultos com diabetes tipo 2 « Portal Tuxauas